Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for smoking cessation
NCT00594204Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing varenicline with placebo (2 arms). Primary endpoint: Number of Participants With 4-week Continuous Abstinence. Started Apr 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00594204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594204.